Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiaxing Lin

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Frontiers in Oncology|December 17, 2020
CD8+ T Cell Co-Expressed Genes Correlate With Clinical Phenotype and Microenvironments of Urothelial CancerYutao Wang, Kexin Yan, Jiaxing Lin, et al.
Scientific Reports|April 7, 2020
The pan-cancer landscape of netrin family reveals potential oncogenic biomarkersWenjun Hao, Meng Yu, Jiaxing Lin, et al.
Aging|November 6, 2020
Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysisYutao Wang, Kexin Yan, Jiaxing Lin, et al.
Bioinformatics (Oxford, England)|May 24, 2018
bcSeq: an R package for fast sequence mapping in high-throughput shRNA and CRISPR screensJiaxing Lin, Jeremy Gresham, Tongrong Wang, et al.
Cell Reports|October 27, 2021
ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cellsJillian Hattaway Luttman, Jacob P Hoj, Kevin H Lin, et al.
Nature Communications|October 7, 2020
Adaptation and selection shape clonal evolution of tumors during residual disease and recurrenceAndrea Walens, Jiaxing Lin, Jeffrey S Damrauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2023
Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13Hazel X Ang, Natalia Sutiman, Xinyue L Deng, et al.
Scientific Reports|November 7, 2018
Genetic variation determines VEGF-A plasma levels in cancer patientsFederico Innocenti, Chen Jiang, Alexander B Sibley, et al.
Nature Cancer|June 6, 2022
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin H Lin, Justine C Rutter, Abigail Xie, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Frontiers in Oncology|December 17, 2020
CD8+ T Cell Co-Expressed Genes Correlate With Clinical Phenotype and Microenvironments of Urothelial CancerYutao Wang, Kexin Yan, Jiaxing Lin, et al.
Scientific Reports|April 7, 2020
The pan-cancer landscape of netrin family reveals potential oncogenic biomarkersWenjun Hao, Meng Yu, Jiaxing Lin, et al.
Aging|November 6, 2020
Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysisYutao Wang, Kexin Yan, Jiaxing Lin, et al.
Bioinformatics (Oxford, England)|May 24, 2018
bcSeq: an R package for fast sequence mapping in high-throughput shRNA and CRISPR screensJiaxing Lin, Jeremy Gresham, Tongrong Wang, et al.
Cell Reports|October 27, 2021
ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cellsJillian Hattaway Luttman, Jacob P Hoj, Kevin H Lin, et al.
Nature Communications|October 7, 2020
Adaptation and selection shape clonal evolution of tumors during residual disease and recurrenceAndrea Walens, Jiaxing Lin, Jeffrey S Damrauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2023
Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13Hazel X Ang, Natalia Sutiman, Xinyue L Deng, et al.
Scientific Reports|November 7, 2018
Genetic variation determines VEGF-A plasma levels in cancer patientsFederico Innocenti, Chen Jiang, Alexander B Sibley, et al.
Nature Cancer|June 6, 2022
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin H Lin, Justine C Rutter, Abigail Xie, et al.
Pageof 5